TY - JOUR
T1 - B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability
AU - Houge, Gunnar
AU - Haesen, Dorien
AU - Vissers, Lisenka E L M
AU - Mehta, Sarju
AU - Parker, Michael J.
AU - Wright, Michael
AU - Vogt, Julie
AU - McKee, Shane
AU - Tolmie, John L.
AU - Cordeiro, Nuno
AU - Kleefstra, Tjitske
AU - Willemsen, Marjolein H.
AU - Reijnders, Margot R F
AU - Berland, Siren
AU - Hayman, Eli
AU - Lahat, Eli
AU - Brilstra, Eva H.
AU - Van Gassen, Koen L I
AU - Zonneveld-Huijssoon, Evelien
AU - De Bie, Charlotte I.
AU - Hoischen, Alexander
AU - Eichler, Evan E.
AU - Holdhus, Rita
AU - Steen, Vidar M.
AU - Døskeland, Stein Ove
AU - Hurles, Matthew E.
AU - FitzPatrick, David R.
AU - Janssens, Veerle
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Here we report inherited dysregulation of protein phosphatase activity as a cause of intellectual disability (ID). De novo missense mutations in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 individuals with mild to severe ID, long-lasting hypotonia, epileptic susceptibility, frontal bossing, mild hypertelorism, and downslanting palpebral fissures. PP2A comprises catalytic (C), scaffolding (A), and regulatory (B) subunits that determine subcellular anchoring, substrate specificity, and physiological function. Ten patients had mutations within a highly conserved acidic loop of the PPP2R5D-encoded B56δ regulatory subunit, with the same E198K mutation present in 6 individuals. Five patients had mutations in the PPP2R1A-encoded scaffolding Aα subunit, with the same R182W mutation in 3 individuals. Some Aα cases presented with large ventricles, causing macrocephaly and hydrocephalus suspicion, and all cases exhibited partial or complete corpus callosum agenesis. Functional evaluation revealed that mutant A and B subunits were stable and uncoupled from phosphatase activity. Mutant B56δ was A and C binding-deficient, while mutant Aα subunits bound B56δ well but were unable to bind C or bound a catalytically impaired C, suggesting a dominant-negative effect where mutant subunits hinder dephosphorylation of B56δ-anchored substrates. Moreover, mutant subunit overexpression resulted in hyperphosphorylation of GSK3β, a B56δ-regulated substrate. This effect was in line with clinical observations, supporting a correlation between the ID degree and biochemical disturbance.
AB - Here we report inherited dysregulation of protein phosphatase activity as a cause of intellectual disability (ID). De novo missense mutations in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 individuals with mild to severe ID, long-lasting hypotonia, epileptic susceptibility, frontal bossing, mild hypertelorism, and downslanting palpebral fissures. PP2A comprises catalytic (C), scaffolding (A), and regulatory (B) subunits that determine subcellular anchoring, substrate specificity, and physiological function. Ten patients had mutations within a highly conserved acidic loop of the PPP2R5D-encoded B56δ regulatory subunit, with the same E198K mutation present in 6 individuals. Five patients had mutations in the PPP2R1A-encoded scaffolding Aα subunit, with the same R182W mutation in 3 individuals. Some Aα cases presented with large ventricles, causing macrocephaly and hydrocephalus suspicion, and all cases exhibited partial or complete corpus callosum agenesis. Functional evaluation revealed that mutant A and B subunits were stable and uncoupled from phosphatase activity. Mutant B56δ was A and C binding-deficient, while mutant Aα subunits bound B56δ well but were unable to bind C or bound a catalytically impaired C, suggesting a dominant-negative effect where mutant subunits hinder dephosphorylation of B56δ-anchored substrates. Moreover, mutant subunit overexpression resulted in hyperphosphorylation of GSK3β, a B56δ-regulated substrate. This effect was in line with clinical observations, supporting a correlation between the ID degree and biochemical disturbance.
UR - http://www.scopus.com/inward/record.url?scp=84939217378&partnerID=8YFLogxK
U2 - 10.1172/JCI79860
DO - 10.1172/JCI79860
M3 - Article
C2 - 26168268
AN - SCOPUS:84939217378
SN - 0021-9738
VL - 125
SP - 3051
EP - 3062
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 8
ER -